Hematological parameters in pre chemotherapy breast cancer patients in a tertiary care centre

Introduction: This study aimed to highlight the degree of derangements of various blood parameters preoperatively in carcinoma breast patients as compared with controls who presented with benign breast disease. Materials and Methods: This was a descriptive study done among clinically diagnosed breast cancer patients attending the central laboratory, at Sapthagiri Institute of Medical Sciences and Research Centre, Bangalore. Results: A total number of 51 cases of prechemotherapy carcinoma breast patients along with controls were subjected to hematological investigations. Anemia was noted in 60% of the cases. The overall mean MCV, MCH, MCHC (79.01± 5.75fl, 26.54± 2.0 pg, 32.70 ± 1.6 g/l respectively) were lower than the controls. Mean TLC (7.73±1.84), RDW (15.18±2.05) and MPV (7.9±0.83), platelet count (3.1±0.8) were seen to be higher than the controls. Conclusion: Breast cancer patients showed deranged hematological parameters as a consequence to the disease.